Triple Negative Breast Cancer Market Analysis and Insights Reveal Dynamic Shifts and Future Growth Projections to 2032
January 24, 2024 10:36 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...
Occlusion Perfusion Catheter Demonstrates Superior Performance in PAD Drug Delivery
November 02, 2023 08:28 ET
|
Advanced Catheter Therapies
Researchers successfully demonstrate the delivery of liquid sirolimus into the arterial wall using the OPC, which can also be used for paclitaxel BTK.
[Latest] Global Paclitaxel Injection Market Size/Share Worth USD 11.4 Billion by 2030 at a 13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 30, 2023 06:30 ET
|
Custom Market Insights
Austin, TX, USA, May 30, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Paclitaxel Injection Market Size, Share, Growth Analysis Report By Indication...
Global Ovarian Cancer Drugs Market Report 2023: Major Players Include AstraZeneca, Roche, Tesaro, Clovis Oncology and Amgen
April 14, 2023 10:28 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Global Ovarian Cancer Drugs Market Analysis, Trends, Opportunity, and Forecasts 2017-2022 & 2023-2027: Growing Prevalence of Ovarian Cancer and Increasing R&D Activities in Development
January 19, 2023 05:43 ET
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By...
AIM ImmunoTech Announces Presentation of New Data from Roswell Park Comprehensive Cancer Center Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Breast Cancer
November 14, 2022 07:00 ET
|
AIM ImmunoTech Inc.
– Data selected for poster presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting – Treatment was well tolerated, with promising clinical activity of pathologic complete...
Drug-eluting Balloon Catheters Market to hit USD 1 billion by 2030, says Global Market Insights Inc.
November 07, 2022 08:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The global drug-eluting balloon catheters market value is poised to surpass USD 1 billion by 2030, according to a new research report by...
Drug-Eluting Balloon Catheters Market to hit USD 916 Million by 2028, Says Global Market Insights Inc.
April 13, 2022 07:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, April 13, 2022 (GLOBE NEWSWIRE) -- Global drug-eluting balloon catheters market value is anticipated to reach USD 916 million by 2028, according to a new research report by...
Global Ovarian Cancer Drugs Market to 2031 - Featuring AstraZeneca, Roche and Tesaro Among Others
March 29, 2022 05:23 ET
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2022, Tumor Type, Distribution Channel, Drug Type" report has been added to ResearchAndMarkets.com's...
Investigation Report on China's CNY1.112 Billion Docetaxel Market 2021-2025
December 31, 2021 05:43 ET
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Docetaxel Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. According to the market...